Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1050 | 924 | 1050 | 1023 | 1280 | 1753 |
Fund Return | 5% | -7.58% | 5% | 0.76% | 5.06% | 5.77% |
Place in category | 312 | 383 | 312 | 298 | 184 | 72 |
% in Category | 44 | 54 | 44 | 55 | 31 | 18 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DFA US Core Equity 1 I | 36.23B | 21.35 | 8.24 | 11.96 | ||
DFA US Core Equity 2 I | 34.43B | 20.27 | 7.92 | 11.38 | ||
DFA International Core Equity I | 30.17B | 3.99 | 1.87 | 5.78 | ||
DFA Emerging Markets Core Equity I | 26.69B | 7.32 | 1.18 | 4.84 | ||
DFA US Large Cap Value I | 24.56B | 12.75 | 5.80 | 8.59 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Intl Stock Index Inv | 201.2B | 5.09 | 0.61 | 5.00 | ||
Vanguard Total Intl Stock Index Adm | 72.9B | 5.14 | 0.67 | 5.06 | ||
Fidelity International Index Inst | 51.28B | 3.71 | 1.71 | 5.38 | ||
Fidelity Series Global ex US Index | 50.22B | 5.35 | 0.85 | 4.86 | ||
Strategic Advisers International I | 44.17B | 5.63 | 0.87 | 6.01 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 2.04 | 575.6 | -4.34% | |
ASML ADR | USN070592100 | 1.35 | 756.33 | +0.81% | |
Louis Vuitton | FR0000121014 | 1.15 | 690.10 | -0.78% | |
Roche Holding Participation | CH0012032048 | 0.98 | 265.40 | -1.19% | |
Novartis ADR | US66987V1098 | 0.95 | 97.53 | -0.34% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Neutral | Buy |
Technical Indicators | BUY | Strong Sell | BUY |
Summary | Neutral | Sell | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review